Summary
The athymic nude mouse has been used as an in vivo model for pharmacologic studies of the antiestrogen, tamoxifen. We hav examined the steady-state serum tamoxifen concentrations achieved in mice with s. c. slow-release pellets, s. c. injections, and i. p. injections, in an attempt to identify a method that would yield serum levels similar to those observed in patients receiving tamoxifen therapy. Tamoxifen and tamoxifen metabolites were examined by a high-performance liquid chromatography assay which has a sensitivity of 8 ng/ml. Tamoxifen metabolites were not observed with any dose or schedule. After slow-release pellets containing 5 or 25 mg tamoxifen no tamoxifen was detectable, even after 2 weeks of treatment. Very low levels (0.07 μM) were found with 50-mg pellets. Tamoxifen was also not detected either with daily s. c. injections of 500 μg/mouse or with i. p. injections of 2.5 mg/kg. However, daily s. c. injections of 1000 μg or i. p. injections of 25, 50, o4 100 mg/kg resulted in tamoxifen concentrations ranging from 0.21 to 0.51 μM which are similar to those observed in patients. Thus, clinically relevant tamoxifen concentrations can be achieved in the nude mouse with either of these methods of administration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brunner N, Spang Thompsen M, Vindelov L, Wolff J, Engleholm SA (1987) Effect of tamoxifen on the receptor-positive T61 and the receptor-negative T60 human breast carcinomas grown in nude mice. Eur J Cancer Clin Oncol (in press)
Fabian C, Sternson L, El-Serafi M, Cain L, Hearne E (1981) Clinical pharmacology of tamoxifen in patients with breast cancer: correlation with clinical data. Cancer 48: 876–882
Osborne CK, Boldt DH, Clark GM, Trent JM (1983) Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res 43: 3583–3585
Osborne CK, Hobbs K, Clark GM (1985) Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res 45: 584–590
Seibert K, Shafie SM, Triche TJ, Whag-Pheng JJ, O'Brien SJ, Taney JH, Huff KK, Lippman ME (1983) Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice. Cancer Res 43: 2223–2239
Shafie SM, Grantham FH (1981) Role of hormones in the growth and regression of human breast cancer cells (MCF-F) transplanted into athymic nude mice. J Natl Cancer Inst 67: 51–56
Soule HD, McGrath CM (1980) Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice. Cancer Lett 10: 177–189
Sutherland RL, Hall RE, Taylor IW (1983) Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells. Cancer Res 43: 3993–4006
Wilbur BJ, Benz CC, DeGregorio MW (1985) Quantitation of tamoxifen, 4-hydroxytamoxifen, and N-desmethyltamoxifen in human plasma by high performance liquid chromatography. Anal Lett 18: 1915–1924
Author information
Authors and Affiliations
Additional information
This work was supported in part by NIH Grant CA 30251 from the National Cancer Institute and the Louis R. Lurie Foundation
Rights and permissions
About this article
Cite this article
DeGregorio, M.W., Wilbur, B.J., Coronado, E. et al. Serum tamoxifen concentrations in the athymic nude mouse after three methods of administration. Cancer Chemother. Pharmacol. 20, 316–318 (1987). https://doi.org/10.1007/BF00262583
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00262583